Background: White spot lesions (WSLs) are a frequent side-effect of multibracket appliance treatment. The effect of local fluoridation on post-orthodontic WSL is however inconclusive. Objective: Assessment of WSL changes in response to weekly 1.25 per cent fluoride gel application after multibracket appliance treatment. Trial design: Randomized, single-centre, double-blind, parallel-group, placebo-controlled study. Participants: Patients with not less than 1 WSL (modified score 1 or 2) on not less than 1 upper front teeth after debonding. Interventions: Professional fluoride/placebo gel application during weeks 1-2; self-administered home application (weeks 3-24). Outcomes: Photographic WSL assessment (dimension and luminance) of the upper front teeth (T0-T5). Randomization: Random assignment to test (n = 23) or placebo group (n = 23) using a sequentially numbered list (random allocation sequence generated for 50 subjects in 25 blocks of 2 subjects each). Recruitment: The clinical study duration lasted from March 2011 to September 2013. Blinding: Unblinding was performed after complete data evaluation. Numbers analysed: Intent-to-treat analysis set comprising 39 participants (test: n = 21, placebo: n = 18). Outcome: Dimensional WSL quantification showed limited reliability. Luminance improvement (%) of WSL, however, was seen after 6 months (test/placebo: tooth 12, 24.8/18.0; tooth 11, 38.4/35.4; tooth 21, 39.6/38.3; and tooth 22, 15.2/25.0). No statistically significant group difference existed. Data suggest that WSLs are difficult to measure with respect to reliability and repeatability and methods for monitoring WSLs in clinical trials require improvement/validation. Harms: Similar adverse events occurred in both groups; none was classified as possibly related to the study product. Limitations: The number of dropouts was higher than expected and the socio-economic status was not assessed. Furthermore, the unknown level of compliance during the home application phase must be considered as limitation.
Introduction
White spot lesions (WSLs) are one of the most undesired iatrogenic side-effects of orthodontic treatments (Txs) involving multibracket appliances (MBAs). These labial surface demineralizations have been reported to occur in up to 96 per cent of individuals undergoing MBA Tx (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Thus, subjects undergoing MBA Tx are more susceptible to WSLs (11) and caries development (12) than untreated subjects.
Initial enamel decalcification can be seen as early as 4 weeks after the beginning of MBA Tx (13, 14) . The incidence for WSL on upper front teeth (UFT) during MBA Tx has been reported to reach 41 per cent of the patients (15) . The lateral incisors seem to have about twice the risk compared with the central incisors (16) .
WSLs usually cease to develop after removal of the MBA because the cariogenic challenge has been removed (17) . In addition, inactive incipient carious lesions may regress and become less prominent (17) (18) (19) . However, they tend to remain visible and may be of aesthetic concern even 5 years after Tx (11) , particularly if they are extensive (17) or exhibit aggravation.
The following risk factors have been revealed: previous WSL and poor oral hygiene before Tx (20) as well as male gender, young age at the start of Tx, long Tx duration, missed appointments, and poor oral hygiene during Tx (16) . During the last decades, different measures besides the need for excellent oral hygiene (5, 21, 22) have been introduced to prevent WSL development during MBA Tx. Especially the oral application of fluoride products is generally accepted to reduce the risk of WSL development (23) (24) (25) (26) (27) . In addition, fluorides have an antibacterial effect (28) (29) (30) which is especially true for highdose fluoride products (31) .
With the aim to enhance enamel remineralization, the effect of local fluoridation on WSLs has been investigated using different types of fluorides and various modes of application (30, (32) (33) (34) . Despite these earlier studies, evidence is still lacking with respect to both the fluoride concentration enabling optimal remineralization (35) and the application mode (36) offering the best chance for WSL remineralization.
Objective
The study objective was to monitor the effect of an intraoral high-concentration fluoride application on the development of WSLs after orthodontic MBA Tx (based on photographical assessment). Null hypothesis (H0): no difference between high-dose fluoride gel and placebo.
Trial design
Single-centre prospective randomized placebo-controlled doubleblind clinical trial.
Subjects and methods

Ethical issue
Before start, the study protocol was approved by the Ethics Committee of the University of Giessen, Germany and the Federal Institute for Drugs and Medical Devices of Germany. In addition, as required by law, the local authorities were acquainted of the study, which was performed in compliance with Good Clinical Practice (GCP) and the Declaration of Helsinki.
Registration
The study was registered with ClinicalTrials.gov (Identifier: NCT01329731).
Patient screening
Healthy MBA patients (11 years and older) from the Department of Orthodontics, University of Giessen, Germany, who had received Tx including the upper jaw for at least 1 year and were scheduled for MBA removal were asked to participate.
Inclusion criteria
-Written informed consent; -Not less than 1 WSL with a modified score 1 or 2 (4) on not less than 1 UFT (in case of lateral incisor aplasia, the replacing canine was taken into account), at debonding; WSL not present on pre-Tx intraoral photographs; -No restorative or prosthetic therapy planned on UFT; and -Agreement not to use any additional oral hygiene products for the whole study duration than the ones received in the study (allowed: oral irrigator, dental floss, and interdental brushes).
Exclusion criteria
-WSL with a modified score 3 (4) on 1 UFT or greater at debonding; -Ongoing oral or dental Tx except emergency Tx; -Known hypersensitivity/allergy to study products and/or materials used; -Professional administration of highly concentrated fluoride products within 30 days prior to enrolment; -Professional administration or home use of highly concentrated fluoride products not related to the study during the whole study; -Alterations of the enamel, e.g. hypoplasia, fluorosis; -Chronic use of medication causing a dry mouth or known xerostomia; -Medication for central nervous system conditions; -Any illness/condition potentially affecting the study outcome; -Known pregnancy or breastfeeding during the course of the study; and -Participation in a clinical trial or receipt of an investigational medication/Tx within the last 30 days
Randomization, blinding, and study products
The subjects were randomly assigned to either a test group (highdose fluoride gel) or a placebo group. Participants who discontinued the study prior to termination of the first week (before T2) were replaced ( Figure 1 ).
Enrolment and assignment were undertaken by blinded staff of the Department of Orthodontics, XXX University of Giessen, Germany, and the clinical duration of the study lasted from March 2011 (first recruitment) to September 2013 (completion).
Colgate-Palmolive Europe provided the necessary amount of study products in sequentially numbered containers (blinded). The random allocation sequence had been generated by ColgatePalmolive Europe, creating a list for 50 subjects randomized into 25 blocks of 2 subjects (the respective list remained with ColgatePalmolive Europe until all study parameters had been fully assessed). In addition, toothbrushes and amine fluoride-containing toothpaste as well as oral hygiene instructions (the participants were asked to brush their teeth at least twice daily) and stopwatches were provided to the participants. (Table 1) . At baseline and at the two following visits (T0 to T2), the operators applied the gel in a standardized way. Cotton rolls were placed labial in the upper jaw, and the teeth were dried with compressed air for 10 seconds. The gel was applied using a rotating rubber cup by the operator who brushed the respective teeth for 20 seconds per tooth. The participants were asked to rinse after 3 minutes and were instructed to refrain from eating and drinking for 1 hour. After the third appointment (T2), the participants were instructed to apply the gel by themselves at home, brushing it onto all teeth for 2 minutes with their regular toothbrush once a week in the evening after regular oral hygiene. They were instructed to spit out the remaining foam and rinse their mouth and refrain from eating and drinking until the next morning. A written instruction was provided.
Treatment protocol and process
At each visit, the participants were asked to fill out a questionnaire concerning medication, dental or medical Tx, and the use of additional fluoride products. In addition, they had been instructed to bring the tube containing the study product to every appointment in order to assess compliance by verifying the weight of the tube.
Photographs of the UFT were taken in a dark room without natural light, using a Nikon digital camera D300 (CMOS Sensor with 12.3 megapixel). A head holder was used to minimize head rotation and/or inclination differences. The participants were instructed to take their habitual occlusion, and the cheeks were retracted using a cheek retractor. The camera was fixed in a stand (Manfrotto 055XPRO B, Junior Geared head 410) at a constant distance between the lens and teeth. The lens was a Nikon AF-S (105/2.8G VR IF-ED Micro) and the flash a Nikon SB-29S TTL ring flash. No polarized filter was used. The digital data were transferred to a PC using Nikon Transfer 1.5.0 software. Digital RAW data were developed in Nikon Capture NX2 software. The images were adjusted for constant brightness, chrominance, and contrast and were saved as TIFF data files. In addition, a hardware-calibrated PC monitor (6500k) was used to ensure standardized settings.
Study parameters
Primary outcome WSL changes in dimension (DWL%) over the 6 months were to be quantified using a computer-assisted analysis. Based on studies by Mattousch et al. (37) and Ferreira et al. (38) , we assumed the extent of remineralization to double and lesion size to halve within 3 months (T4) of Tx (primary study parameter).
All measurements were performed twice by the same calibrated and blinded investigator (LS) with a time interval of at least 2 weeks between the measurements.
The WSL changes were to be assessed from digital intraoral photographs obtained for each study participant at each assessment point using the software Image Pro Plus (Version 7.0, Media Cyberkinetics, Santa Clara, California, USA). The image analysis software was set to calculate the area of the WSL in relation to the total tooth surface. The outline of each of the four UFT was traced by means of a freehand tool with the computer mouse. The software calculated the pixel size to determine the total area of each tooth. Afterwards, the software calculated the size of the WSL by automatically detecting the brightest area of the tooth surface. To exclude all areas that were not part of the WSL (such as reflections being caused by the flash light), the borderlines of the WSL were corrected manually.
Secondary outcome
As the method of WSL quantification proved to have limited reliability, a second endpoint (WSL luminance) was introduced prior to data unblinding. This endpoint was chosen according to the following considerations: the severity/visibility of an enamel demineralization is proportional to the degree of the mineral loss of the enamel which, in turn, changes its optical properties (39) (40) (41) (42) (43) . Thus, the severity of the WSLs was to be quantified on the basis of their colour changes
Eligible patients n=210
Declined to participate n=162
Control group (Placebo) n=23
Test group (High-dose fluoride) n=23
Follow-up Data analysis
Data sets n=23
Data sets n=23
ITT-Analysis n=18
ITT-Analysis n=21
Randomised n=48
Missed visit T4 n=5
Missed visit T4 n=2
Drop out during week 1 -> replaced n=1
Drop out during week 1 -> replaced n=1 Figure 1 . Flow chart of the study patients.
according to the Commission Internationale de l'Éclairage (CIE) Lab system. This method has been shown to be an objective tool for tooth colour determination (44, 45) . The software used to detect the changes in luminance was Adobe Photoshop CS5 Extended (Version 12.0x64), licensed for medical use.
For luminance assessment, all pictures were evaluated in real pixel size (100 per cent). The outline of each tooth was traced by means of a freehand tool using the computer mouse. The software calculated the number of pixels and a respective RGB value as well as mean, standard deviation, and central value. In addition, the mean luminance was measured for each tooth's total labial surface. Afterwards, the luminance of the WSL was measured by identifying its brightest area with the pipet tool. In addition, the luminance of healthy enamel was measured at two healthy sites of the tooth surface. The mean of these two values was used as reference for 'normal' tooth colour.
Sample size calculation
Sample size calculation was carried out by means of a two-sided Wilcoxon-Mann-Whitney U-test at a significance level of α = 0.05.
In the group treated with the placebo gel, we assumed a distribution of DWL% as mentioned by Willmot et al. (46) . In this in vitro trial, the investigator observed a mean DWL% of 8.1 for 21 teeth with WSLs. For ΔDWL% from baseline to 12 weeks (no fluoride application), they observed a mean of 3.6 with an SD of 2.0 corresponding to a reduction of 44.4 per cent. For our study, due to high-dose fluoride application we assumed a value of 5.4 for the test group, which corresponds to a reduction of 66.7 per cent and was regarded as the minimal clinically relevant effect on which the sample size calculation was based.
A sample size of 21 patients per group yields 80 per cent power to detect the clinically relevant effect for a two-sided unpaired t-test. To account both for the relative asymptotic efficiency between the two-sided unpaired t-test and Wilcoxon-Mann-Whitney U-test and dropout, an additional 10 per cent of patients were randomized per group, i.e. 46 patients in total.
Statistical analysis
The primary efficacy variable was the difference in DWL% from T0 to T4 (baseline to assessment at 12 weeks): ΔDWL% = DWL% (T4) − DWL% (T0). This was calculated for both study products, and mean data were compared statistically.
Because of the small sample size, the statistical hypotheses were assessed by the Wilcoxon-Mann-Whitney U-test. The primary efficacy analysis (T0-T4) was performed for the intent-to-treat (ITT) population (all participants who attended visits T0 and T4, irrespective of T1 to T3). The significance level was set to α = 0.05. There was no adjustment for multiplicity of tests.
In addition, the reliability for the measurements of both study parameters was assessed using an intrarater reliability coefficient (47) based on the two replicated measurements (Figure 4) .
Results
Patient flow and adverse events
A total of 48 patients were included in the study. Two participants missed their appointment during the first week of the trial (T1) and were replaced after dropping out. The ITT analysis set was comprised of 39 participants (7 dropouts due to missed appointment T4); test group: 9 male and 12 female and placebo group: 8 male and 10 female. Several similar adverse events (most common: common cold with cough and fever, headache, rhinitis and sore throat) occurred frequently in both groups during the trial, but none of them was classified as possibly related to the study products.
Baseline findings
The two groups were comparable with respect to age, gender, and other baseline characteristics ( Table 2 ). The sample consisted of 20 males (42 per cent) and 28 females (58 per cent) with a mean age of 15.3 years. The general health status at T0 was predominantly unremarkable; 2 of the 48 patients suffered either from rheumatism or Marfan syndrome. Both diseases are not known to affect WSL or any related parameter.
Primary outcome: WSL dimension (DWL%)
Many WSLs displayed severely diffuse margins that hampered the accurate determination of lesion borders thus, reliably and validly tracing the WSLs proved to be difficult or even impossible. These diffuse margins were most probably due to the large size of the images that were evaluated at (100 per cent = real pixel size). As the first and second measurements of the relative WSL areas deviated by as much as 70 per cent, the method of quantifying WSL changes in dimension (DWL%) using a computer-assisted analysis proved to be unreliable (after study completion). Thus, interpreting the results, the rather large method error for this variable needs to be kept in mind (Supplementary Tables 1 and 2 ).
The baseline values of WSL dimension (T0) were similar in both groups, showing no statistically significant difference. The same was true for the values from T1 to T5. Looking at the changes seen after 12 weeks (T0-T4) and 24 weeks (T0-T5) of Tx, greater reductions in WSL dimension were seen for the lateral incisors in the placebo group (11.1 to 21.8 per cent) compared with the test group (−4.6 to 10.8 per cent). The central incisors, however, showed greater effects in the test group (47.7 to 48.6 per cent) compared with the placebo group (23.1 to 41.1 per cent). Nevertheless, no statistically significant group difference was seen.
Secondary outcome: WSL luminance
The baseline (T0) luminance values were similar in both groups showing no statistically significant group difference (Supplementary  Tables 3 and 4 , Figures 2 and 3) . For the lateral incisors, the mean values were 12.1 ± 5.1 (test 12) and 10.5 ± 5.4 (test 22) and 10.6 ± 3.7 (placebo 12) and 12.8 ± 4.5 (placebo 22), respectively. The values for the central incisors were 8.6 ± 3.9 (test 11) and 9.6 ± 3.9 (test 21) and 7.9 ± 3.3 (placebo 11) and 8.1 ± 3.4 (placebo 21), respectively.
For the final luminance values, no statistically significant group difference existed neither for the endpoint T4 nor for T5. The luminance values ranged between 8.8 ± 3.5 and 9.6 ± 3.9 for the lateral incisors and between 5.7 ± 3.0 and 6.2 ± 3.1 for the central incisors in both groups, respectively.
Looking at the changes seen after 12 weeks (T0-T4) and 24 weeks (T0-T5) of Tx, slightly greater reductions in WSL dimension were seen in the test group (21.9 and 37.4 per cent) compared with the placebo group (20.0 and 29.4 per cent) Nevertheless, no statistically significant group difference was seen.
Discussion
The 48 included subjects were patients of the Department of Orthodontics at the University of XXX with a mean age of 15.3 years at the time of inclusion (after at least 12 months of MBA Tx) and-due to strict inclusion/exclusion criteria-similar dental characteristics, making them a representative sample.
Unfortunately, the number of dropouts was distinctly higher than expected (mainly due to minor sicknesses and the rather tight study regime). Nevertheless, 39 participants qualified for the ITT population, which corresponds to a dropout rate of 15 per cent. The ITT population was defined as all participants who did not miss visit T4 (primary efficacy analysis: T0-T4). The gender distribution was 28 females versus 20 males which is in concordance with the total patient sample of the department. While females generally do exhibit a greater interest in oral health (48) and orthodontic Tx (49) , it remains inconclusive whether girls have a higher risk for WSL development during MBA Tx or boys (4, 16, 50) . The socio-economic status was not considered in this trial; due to the randomization, however, it should be similar in both groups.
The WSLs showed a degree 1 or 2 at the start of Tx. These inclusion criteria were chosen to ensure the existence of a continuous enamel surface that offers the possibility for remineralization (51) in contrast to lesions exhibiting cavitation, which are non-reversible and demand invasive Tx (52, 53) . In addition, in concordance with previous studies (30, 34) , intraoral photographs from before orthodontic Tx were examined to ensure no WSL had been present pre-Tx.
The participants were instructed to use only the oral hygiene products handed out by the study centre, as additional fluoride application might have influenced the study results. However, it was impossible to ensure that this directive was followed. While a respective questionnaire was filled out at each visit, a certain bias cannot be ruled out. The same is true for the home application of the study product. While all participants received oral and written instructions on usage and were asked to bring the product to each visit for weight assessment, no full control was possible. So, alike in previous studies, compliance must be considered as a possible confounding factor (54, 55) .
Several methods for the detection, quantification, and monitoring of WSLs are described in literature. While histologic analysis and transverse microradiography are the gold standards, these variables are not suitable for clinical WSL assessment.
Several in vitro and in vivo studies (37, (56) (57) (58) (59) (60) employed quantitative light-induced fluorescence (QLF). Although the results of recent QLF studies are promising (61) (62) (63) , the validity of clinical QLF use remains questionable. Inconsistent handling by the investigator, remaining surface moisture, and the presence of plaque or tartar are considered possible sources of error (56, 57) . In addition, WSLs after removal of orthodontic treatment, with their typical location and shape, were not assessed in most studies. Because these WSLs tend to Table 2 . Baseline data of the 48 randomized patients. Sex and ethnic origin for the test and placebo groups are given as well as age, WSL dimension (DWL%) and WSL luminance (difference between the brightest spot and healthy enamel) for the teeth 12-22, which includes the mean value (Mean) and standard deviation (SD) for these variables. WSL = white spot lesions. be large, constant illumination with optimal intensity is difficult (56, 57, 61) . Nevertheless, the application of QLF changes as additional parameter might have revealed further worthwhile findings.
Computer-based analysis of WSLs on photographs has been employed for in vivo quantification frequently (46, 56, 57, (64) (65) (66) . However, it is difficult to standardize the photographs since light conditions, distance between the lens and tooth, and the angle of the camera-tooth surface have to be kept constant (34, 46, 56, 57) . Therefore, a head/neck holder, constant distance between camera and object and constant light conditions in a windowless room were used in the present investigation. However, minimal rotations of the head as well as artefacts due to lightning could not be completely eliminated. No polarized filter-which might have reduced the reflections-was used. The evaluation of intraoral photographs has been reported to be at least as valid as a clinical examination in case of constant conditions (16, 46, 64, 67, 68) and to have a high reproducibility (16, 69) . This, however, is not in concordance with the results of the present study where a difference of up to 70per cent was seen between the first and second surface measurements. So, according to the present investigation, the method of surface measurement on digital high-resolution photographs was non-reliable ( Figure 4) . A reason might be the increased resolution of current digital photographs compared to analogue photographs resulting in a very detailed image where even the slightest enamel anomaly is visible. In addition, magnification might play a role as the photographs were evaluated on a computer screen and assessed at 100 per cent pixel size in the present investigation.
As an alternative to measuring the size of WSLs, a WSL severity evaluation according to the CIELab system, measuring the brightness in terms of luminance was introduced (prior data unblinding) because a WSL size does not necessarily correlate with its severity (42) . As WSL visibility depends not only on the WSL itself but also on the surrounding tooth colour (43) , the luminance of the WSL relative to the luminance of the surrounding enamel was measured in the present investigation. Furthermore, as the tooth colour varies within a tooth surface (41, 70) , the luminance was measured at two different tooth sites (gingivally and incisally). This method proved to be more reliable than the one for the primary study parameter WSL dimension (Figure 4) . While the literature offers some studies where WSL were evaluated on digital photographs (16, 20, 25, 30, 71) , the study designs varied considerably in terms of materials and methods, which does not allow for a direct comparison of the results. Willmot (34) analysed the application of a low-dose fluoride mouth rinse (50 ppm) compared with a placebo. The WSL changes were assessed using scanned intraoral analogue photographs (which probably were of much lower quality than those used in the present study). However, no significant group difference was seen regarding WSL size reduction. This is in line with the present results showing a clear luminance reduction as a sign for the improvement of the WSLs in both groups without a statistically significant group difference.
An in vitro investigation by Ballard et al. (72) evaluating the changes of artificial WSL on extracted premolars showed distinct luminance reductions for all test groups compared with a control group. In the test groups, different products (among others one with a similar fluoride contents as in the present study-1.1 per cent) were used over a 28-day period. These products were applied twice daily which could explain the difference in effect size. Unfortunately, this protocol cannot be adapted clinically due to potential toxic effects (52) . In any case, as the luminance changes were only assessed for the WSL and not for the surrounding enamel, no direct comparison to the present data can be performed. Knösel et al. (73) also assessed the luminance changes of teeth with WSLs after MBA Tx. While the performed Tx (resin infiltration) is not comparable to the present study, the values of the untreated control group are. The respective mean WSL luminance value at baseline was 73.12 ± 3.81, the value of the surrounding enamel was 72.46 ± 2.64; therefore, as only a very small difference in luminance existed, the WSLs must have been very mild. This might also explain why almost no luminance reduction was observed after an observation period of 6 months (WSL 72.78 ± 4.16 and enamel 72.42 ± 2.51).
Thinking about WSL development after MBA Tx in general, the balance between protective and pathologic factors will influence the respective direction of changes-regression or progression (74) . In both groups of the present investigation, improvement of the WSLs was seen except for 12 of the 66 affected teeth in the test and 12 of the 54 affected teeth in the placebo group. It was not surprising to find WSL reduction in the placebo group as well, as this effect has been reported before (37, 69, 75, 76) . After removal of the MBA appliance, WSL development generally stops and initial lesions can become inactive in the absence of cariogenic factors/good oral hygiene (17, 75) . Even saliva itself is able to remineralize initial lesions (77, 78) . In a long-term observation, Shungin et al. (69) found that the majority of natural WSL changes take place during the first and second year after MBA removal. In contrast, Mattousch et al. (37) observed natural WSL improvement during the first 6 months after MBA removal only.
While the use of low-dose (not greater than 0.025 per cent) fluoride products (30, 34) and the use of a high-dose product (5.0 per cent) for 8 weeks (79) did not evoke an effect compared with the untreated controls, a positive effect was seen when applying a product with a high fluoride concentration (5.0 per cent) for 6 months (32) . Nevertheless the use of high-dose fluoride products for WSL Tx is still controversial. Some studies reported an effect of hypermineralization but without achieving an aesthetic improvement (21, 80) . Nevertheless, fluoridated enamel and also lesions will be more resistant to acid attacks and therefore prevent a progression in terms of cavity development (81, 82) .
Limitations
Several limitations have to be considered when evaluating the results of the present randomized controlled trial. First of all, the number of dropouts was much higher than expected. However, due to randomization both the test and the placebo groups were affected. Another limitation regarding the study population is the socio-economic status, which was not assessed. But again, due to randomization, the respective structure should be similar in both groups.
Another limitation certainly is the compliance. Due to practicability reasons, it was impossible to assess whether the participants followed the instructions on oral hygiene and fluoride/study product application during the second (home use) phase. While efforts were made to control this uncertainty (questionnaire and assessment of tube weight upon each visit), compliance must be considered as a possible confounding factor.
Generalization
The results of the present study can be generalized for patient groups with a similar mean age (approximately 15 years), inclusion/exclusion criteria [especially with respect to the initial WSL with a modified score 1 or 2 (4)] and treatment protocol (especially in terms of the study products' fluoride concentration).
However, as the present investigation did not result in conclusive evidence regarding the Tx of WSL which developed during orthodontic MBA Tx, several open questions remain and the data clearly indicate a further need for improvement and validation of the methods for monitoring WSLs in clinical trials.
Conclusion
In the present study, no significant positive effect of high-dose fluoride (1.25 per cent) Tx on post-orthodontic WSL development (based on a photographical assessment of WSL luminance) could be detected compared with the placebo Tx. However, as the trial statistic was designed to show superiority of high-dose fluoride Tx, non-significant intergroup findings do not prove that treatment groups are equivalent.
Supplementary material
Supplementary material is available at European Journal of Orthodontics online.
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